Carasent AB (publ) (STO:CARA)
Sweden flag Sweden · Delayed Price · Currency is SEK
24.95
+0.09 (0.34%)
At close: May 2, 2025

Carasent AB Revenue

Carasent AB had revenue of 85.18M NOK in the quarter ending March 31, 2025, with 28.88% growth. This brings the company's revenue in the last twelve months to 294.35M, up 17.12% year-over-year. In the year 2024, Carasent AB had annual revenue of 275.26M with 12.27% growth.

Revenue (ttm)
294.35M NOK
Revenue Growth
+17.12%
P/S Ratio
6.39
Revenue / Employee
1.48M NOK
Employees
199
Market Cap
1.79B SEK

Revenue Chart

* This company reports financials in NOK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024275.26M30.08M12.27%
Dec 31, 2023245.18M49.92M25.57%
Dec 31, 2022195.26M58.14M42.40%
Dec 31, 2021137.13M66.55M94.29%
Dec 31, 202070.58M22.65M47.26%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 26.24B
Sectra AB 3.30B
Getinge AB 35.57B
Camurus AB 1.87B
Medicover AB 23.56B
AddLife AB 10.42B
Vitrolife AB 3.61B
Vimian Group AB 4.24B
Revenue Rankings